About the NEI ORM
The NEI Office of Regenerative Medicine (ORM) provides scientific and administrative support to the vision research community. The ORM facilitates collaboration among scientists across the NIH and other federal agencies, academia, and nonprofit and private research sectors. ORM’s goal is to accelerate progress in regenerative medicine for vision.
Events and Announcements
New Funding Opportunity: NEI Regenerative Medicine Clinical Trial Planning Grant
June 1, 2022: 3-D ROC Final Submission Deadline
This is the final phase of 3-D ROC. Solvers must submit by this deadline - see more details on our 3-D ROC page.
NEI has launched a webinar series to help promote and disseminate cutting-edge research that is relevant to the vision community. Authors of recently published articles will present their work to the research community through this monthly webinar series.
NEI is pushing the boundaries of vision science. By facilitating cross-disciplinary research, the AGI is advancing regenerative medicine to tackle the most devastating and difficult-to-treat eye diseases.
3-D ROC is spurring development of robust systems for modeling retinal diseases and testing new regenerative therapies.
NEI is taking the first important steps to correlate phenotypes, genotypes, and imaging information in the newly created AMD Integrative Biology Initiative.
This trans-NIH effort was established by the 21st Century Cures Act to accelerate progress in the field by supporting clinical research on adult stem cells, while promoting scientific rigor and protecting patient safety.